Shamburg News · 8-K filed Nov 17, 2026, 8:30 AM EST
Dermata Therapeutics Highlights Cosmetic Study Results and Over 1,000 Tome Orders
DRMA · Dermata Therapeutics, Inc.
- Other event
- Materiality: low
On November 17, 2026, Dermata Therapeutics, Inc. issued a press release highlighting additional results and photos from a recently completed cosmetic clinical study of its Tome Foundational Treatment, a once-weekly skin renewal treatment. The company stated it has received over 1,000 orders for the product since its launch.
Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001493152-26-052715.
Written from the filing by Shamburg Markets. Figures are as reported by the company.